Literature DB >> 15522325

Effect of an EGF-cancer vaccine on wound healing and inflammation models.

A Casacó1, Y Díaz, N Ledón, N Merino, O Vadés, G Garcia, B Garcia, G González, R Pérez.   

Abstract

BACKGROUND: Epidermal growth factor (EGF) and its receptor (EGF-R) are attractive targets for cancer immunotherapy. Tolerance has been broken with an EGF-vaccine and antibodies against EGF have been produced in animals and in cancer patients. EGF also plays an important role in the inflammation stage of wound healing. Because this therapeutic approach may be of importance after surgery procedures in cancer patients, we decided to investigate the possible role of the EGF-vaccine in the croton-oil-induced ear edema and in the wound healing experimental animal models.
MATERIALS AND METHODS: Mice were immunized with an EGF-vaccine by intramuscular injections and serum titers against EGF were measured through ELISA techniques. Control animals received saline.
RESULTS: Immunized mice produced antibodies against EGF while no antibody titers could be measured in control animals. Croton oil applied to the inner ear surface of EGF-vaccine treated mice caused a 61.3% lower ear punch weight and a 60.2% lower myeloperoxidase activity than control mice. In the EGF-vaccine treated animals, planimetry measurements and histological analysis did not led to significant impairment in tissue repair.
CONCLUSIONS: The EGF-vaccination in mice decreased the normal croton-oil-induced inflammation response, without apparent impairment in tissue healing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522325     DOI: 10.1016/j.jss.2004.06.008

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  NFAT3 is required for EGF-induced COX-2 transcription, but neither iNOS transcription nor cell transformation in Cl 41 cells.

Authors:  Jingxia Li; Haitian Lu; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

2.  Effects of an epidermal growth factor receptor-based cancer vaccine on wound healing and inflammation processes in murine experimental models.

Authors:  Dasha Fuentes; Lewis Chacón; Angel Casacó; Nuris Ledón; Nidia Fernández; Arianna Iglesias; Diana R Hernández; Belinda Sánchez; Rolando Pérez
Journal:  Int Wound J       Date:  2012-09-04       Impact factor: 3.315

Review 3.  A new hypothesis for the cancer mechanism.

Authors:  Xiaolong Meng; Jie Zhong; Shuying Liu; Mollianne Murray; Ana M Gonzalez-Angulo
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

4.  Effect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF.

Authors:  Aymara Fernández Lorente; Soraida Acosta Brooks; Elia Neninger Vinageras; María del Carmen Barroso Alvarez; Barbara Wilkinson Brito; Mayelin Troche Concepción; Liana B Martínez Pérez; Carmen E Viada González; Tatiana Crespo Diaz; Angel Raymundo Casacó Parada
Journal:  World J Surg Oncol       Date:  2013-10-15       Impact factor: 2.754

5.  Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer.

Authors:  Puyuan Xing; Hongyu Wang; Sheng Yang; Xiaohong Han; Yan Sun; Yuankai Shi
Journal:  BMC Immunol       Date:  2018-04-16       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.